Key result
Viral gene transfer targeting central noradrenergic neurons clarifies catecholaminergic drivers of cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Numerous studies, some of which date back more than three decades, have established a link between disorders of the cardiovascular system and the catecholaminergic system of the brain. Central noradrenergic (and putative adrenergic) neurones are involved in numerous brain functions, and there appears to be more than one mechanism via which a dysfunction of central nor/adrenergic signalling may be detrimental to the cardiovascular system. Moreover, in some cases, such as essential hypertension, altered noradrenergic transmission could play a causative role. Numerous controversies are evident throughout the literature, which are very difficult to explain without much better understanding of the basic physiology of central noradrenergic transmission. Recently, using a combination of novel molecular, electrochemical and imaging techniques, we have started to unravel how noradrenergic neurones in the brain store and release their transmitter. Targeted long-term modulation of specific noradrenergic cell groups in defined brain areas using viral gene transfer is helping to clarify the links between central catecholamines and cardiovascular control in health and disease. These studies may reveal new therapeutic strategies for various cardiovascular diseases which are accompanied by heightened sympathetic nerve activity.
No takes yet. Share an insight, caveat, or question.
Kasparov et al. (2008) conducted a review in Cardiovascular disease and essential hypertension. Altered central catecholaminergic transmission and targeted viral gene transfer was evaluated. Targeted modulation of central noradrenergic neurones via viral gene transfer helps clarify how altered catecholaminergic transmission contributes to cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: